At the 2026 Life Rebalanced Live virtual conference, the Vestibular Disorders Association (VeDA) opened the week with an important conversation about innovation in vestibular care. The session, Hope in Innovation: Emerging Therapies for Chronic Dizziness, explored how research, technology, and patient experience are shaping the future for people living with dizziness and balance disorders.
The discussion featured two vestibular experts—Dr. Sue Whitney, DPT, PhD, and Dr. David Hale, MD—followed by a patient panel with Neil Canham and Alicia Wolf, also known as The Dizzy Cook. Together, they highlighted the promise of new ideas in the field while emphasizing the importance of evaluating emerging therapies carefully and thoughtfully.
Innovation Is More Than New Technology
When people think about innovation in medicine, they often imagine new devices or medications. But the speakers emphasized that innovation in vestibular care goes far beyond technology.
Dr. Hale described innovation as new ways of approaching diagnosis, treatment, and education in the vestibular field. One major example is the development of clearer diagnostic criteria for conditions such as vestibular migraine and persistent postural-perceptual dizziness (PPPD). These frameworks help clinicians identify conditions more accurately, making it easier to study them and develop targeted treatments.
Another form of innovation is collaboration. Vestibular care increasingly involves multidisciplinary teams, bringing together neurologists, otolaryngologists, physical therapists, and other specialists. By combining expertise across fields, clinicians can better understand complex symptoms and provide more comprehensive care.
Turning Research Into Real-World Care
One way research reaches patients is through clinical practice guidelines. Dr. Whitney explained that these guidelines help translate scientific evidence into recommendations that clinicians can use in everyday care.
Developed by multidisciplinary teams of experts, guidelines summarize the best available evidence for diagnosing and treating vestibular disorders. They help reduce unnecessary variations in treatment while still allowing clinicians to adapt care to each patient’s needs.
For patients, this means that evidence-based care is becoming more widely accessible—even in places where specialized vestibular providers may not be available.
The Growing Importance of the Patient Experience
Another major shift in vestibular research is the increasing recognition of patients’ lived experience.
Researchers are beginning to incorporate patient perspectives when designing studies, developing diagnostic criteria, and evaluating treatment outcomes. Large data collection tools—such as patient registries and standardized questionnaires—are helping researchers understand how vestibular disorders affect daily life.
By collecting information from thousands of individuals, researchers can identify patterns in symptoms, triggers, and recovery. These insights can guide the development of more effective therapies and improve future clinical guidelines.
Technology Is Changing Vestibular Care
Advances in technology are also opening new possibilities for diagnosing and managing vestibular disorders.
For example, smartphones and wearable devices can now capture eye movement recordings and symptom episodes outside of a clinic visit. These recordings can help clinicians better understand what patients experience during dizzy episodes.
Telehealth has also expanded access to vestibular care. Virtual visits allow clinicians to observe how symptoms affect patients in their everyday environments, sometimes revealing clues that would not appear during an office visit.
In addition, tools such as virtual reality systems, mobile health apps, and digital education platforms are helping clinicians train other providers and improve access to specialized knowledge around the world.
Barriers That Slow Progress
Despite these promising developments, significant challenges remain.
One of the biggest barriers is limited funding for vestibular research. Compared to many other medical conditions, dizziness and balance disorders receive relatively little research funding. This limits the number of large clinical trials that can test new treatments.
Another barrier is diagnosis. Many people with vestibular disorders spend years seeking answers before receiving an accurate diagnosis. Without a diagnosis, it is difficult to determine which treatments may be effective.
Improving education for healthcare providers and raising awareness of vestibular disorders are key steps toward overcoming these challenges.
Balancing Hope With Healthy Skepticism
Both clinicians and patients emphasized the importance of balancing optimism about new therapies with careful evaluation.
People living with chronic dizziness often search widely for solutions, which can make them vulnerable to treatments that promise quick results but lack scientific evidence.
Dr. Hale encouraged patients to discuss potential therapies with their healthcare providers and to ask whether treatments are supported by reputable research organizations or clinical studies.
In other words, innovation should bring hope—but it should also be guided by evidence and safety.
Patients Navigating Innovation
The patient panel brought these ideas into focus through real-world experiences.
Alicia Wolf shared how her journey with vestibular migraine involved working closely with neurologists to test emerging therapies, including neuromodulation devices designed to stimulate specific nerves associated with migraine. While some of these tools have been helpful for her, she emphasized that they work best as part of a broader treatment plan that includes medication, lifestyle changes, and other therapies.
Neil Canham, who has lived with Ménière’s disease for many years, spoke about the importance of understanding scientific research. Not all studies provide the same level of evidence, he explained, and learning how to evaluate research can help patients make more informed decisions.
Both panelists emphasized the importance of curiosity paired with skepticism when exploring new treatments.
Looking Toward the Future
As the session concluded, both experts shared what they hope to see in the next decade of vestibular medicine.
Dr. Whitney hopes that researchers will uncover clearer answers about the underlying causes of vestibular disorders and develop treatments supported by strong scientific evidence.
Dr. Hale emphasized the need for more clinicians trained in vestibular care, ensuring that people everywhere have access to knowledgeable providers.
Together, these goals reflect a future where vestibular disorders are better understood, diagnosed more quickly, and treated more effectively.
Moving Forward With Hope
Innovation in vestibular care is happening in many ways—through new technologies, improved diagnostic criteria, better research tools, and stronger partnerships between clinicians and patients.
Progress may take time, but the field continues to move forward. As researchers, healthcare providers, and patient advocates work together, they are building a future where people living with dizziness have more answers, more options, and more hope than ever before.
